Growth in New Drugs to Give a Boost to Roche (RHHBY) Q1 Sales
http://www.zacks.com/stock/news/880340/growth-in-new-drugs-to-give-a-boost-to-roche-rhhby-q1-sales?cid=CS-ZC-FT-analyst_blog|earnings_preview-880340
Apr 20, 2020 - Roche's (RHHBY) newer drugs are likely to have combated the biosimilar competition for legacy drugs in the first quarter.
0
Will Pfizer's (PFE) BioPharma Unit Q1 Earnings Increase?
http://www.zacks.com/stock/news/887532/will-pfizers-pfe-biopharma-unit-q1-earnings-increase?cid=CS-ZC-FT-analyst_blog|earnings_preview-887532
Apr 24, 2020 - In Pfizer's (PFE) Biopharma unit, oncology sales are likely to have risen in the first quarter, while in non-oncology, Xeljanz and Eliquis alliance revenues are likely to have supported the top line.
0
Big Drug Stock Q1 Earnings Due on Apr 28: MRK, PFE and NVS
http://www.zacks.com/stock/news/891794/big-drug-stock-q1-earnings-due-on-apr-28-mrk-pfe-and-nvs?cid=CS-ZC-FT-analyst_blog:_earnings_preview_-_esp|earnings_preview_-_esp-891794
Apr 27, 2020 - Let us take a look at three big drug companies due to release their first-quarter financial results on Apr 28.
0
A Plethora of Q1 Earnings Results: MMM, CAT, PEP & More
http://www.zacks.com/stock/news/893951/a-plethora-of-q1-earnings-results-mmm-cat-pep-more?cid=CS-ZC-FT-ahead_of_wall_street-893951
Apr 28, 2020 - A big morning for Q1 earnings reports joins a new Advance Trade in Goods report out this morning. Pre-market indexes are way in the green at this hour.
0
Why Merck (MRK) is a Top Dividend Stock for Your Portfolio
http://www.zacks.com/stock/news/911521/why-merck-mrk-is-a-top-dividend-stock-for-your-portfolio?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-911521
May 01, 2020 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes? Let's find out.
0